CIBBIM - Nanomedicine
CIBBIM-Nanomedicine. Molecular Oncology
Diego Arango
Team Jose Higinio Dopeso, Josipa Bilic, Sarah Bazzocco, Elena Andretta, Fernando Carton, Irati Macaya, Lizbeth Jiménez, Priscila Marcondes, Rocio Nieto, Yaiza Núñez
Summary
During the year 2015, our group was able to obtain funding from highly competitive calls like the Spanish Association Against Cancer (AECC) and the European Union (H2020). Two new international PhD students joined the group and one PhD thesis was defended, achieving the highest marks (Excellent Cum Laude). In addition, we published the results of several studies, including 1) the identification of novel therapeutic targets for patients with colorectal cancer, whish also led to patent (Bazzocco et al 2015 Clinical Cancer Research), and 2) the characterization of the first available murine model of microvillus inclusion Disease (MVID), a devastating hereditary syndrome resulting from mutations in the gene MYO5B and that causes intractable, life-threatening watery diarrhea immediately after birth (Carton et al 2015 Scientific Reports). Importantly, our group also moved to a new location within the Vall d´Hebron campus, at the Collserola Building together with the rest of the groups of the Area of Oncology Research.